Intrathecal 2-hydroxypropyl-�-cyclodextrin Decreases Neurological Disease Progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial
Lancet 390:1758-1768, Ory, D.S.,et al, 2017
The Neurobiology, Diagnosis, and Treatment of Narcolepsy
Ann Neurol 53:154-166, Scammell,T.E., 2003
Niemann-Pick Disease Type C from Bench to Bedside
JAMA 276:561-564, Schiffmann,R., 1996
The Narcolpetic Syndrome
JNNP 59:221-224, Parkes,J.D.,et al, 1995